Skip to content

Physical Function in Patients With Chronic Obstructive Pulmonary Disease

Physical Function in Patients With Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04107831
Enrollment
50
Registered
2019-09-27
Start date
2019-08-09
Completion date
2024-12-31
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

Pulmonary rehabilitation, Exercise, Field walk test, Physical performance test

Brief summary

The aims of the study are to examine the responsiveness of, and the correlation between field walk tests and physical performance test in patients with chronic obstructive pulmonary disease (COPD) after participating in pulmonary rehabilitation.

Detailed description

Patients with COPD who are participating at pulmonary rehabilitation (PR) at Haukeland University Hospital will be asked and consecutive enrolled to the study. Before and after PR the six-minute walk test, incremental- and endurance shuttle walk test, 30 sec sit-to-stand test and stair test will be used to evaluate change in physical capacity and -performance.

Interventions

OTHERPulmonary rehabilitation

Pre-post test design

Sponsors

Norwegian Fund for Postgraduate Training in Physiotherapy
CollaboratorOTHER
Western Norway University of Applied Sciences
CollaboratorOTHER
Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosed with COPD, Forced expiratory volume in 1 sec (FEV1)/Forced vital capacity (FVC) \<0.7 and FEV1\<80% of predicted value. * Able to walk corridor and stairs * Norwegian speaking

Exclusion criteria

* COPD exacerbations requiring medical treatment last 4 weeks prior to inclusion led to deferment of inclusion * Not safe to exercise (e.g unstable angina) * mental illness and drug abuse that makes group treatment not suitable

Design outcomes

Primary

MeasureTime frameDescription
6-minute walk testup to 6 weeksChange from baseline to 6 weeks in 6 minute walk distance in meter is primary outcome

Secondary

MeasureTime frameDescription
Incremental Shuttle walk testup to 6 weeksChange from baseline to 6 weeks in walk distance in meter is the outcome
Endurance shuttle walk testup to 6 weeksChange from baseline to 6 weeks in time in second is the outcome
30 second sit to stand testup to 6 weeksChange from baseline to in number of repetition is the outcome
Stair testUp to 6 weeksChange from baseline to 6 weeks in time of the test is the outcome: 18 steps are walked up and down three times as fast as possible. Time in sec. is measured.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026